Comparative steady-state bioavailability of sustained-release theophylline preparations: Theo-Dur®, Uni-Dur® and Xanthium®

Asian Pacific Journal of Allergy and Immunology

Volumn 19, Issue 2, 2001, Pages 69-78

  Rojanasthien, N ^a   Kovjiriyapan, K ^a   Manorot, M ^a   Pothirat, C ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

FRANOL; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSAGE FORM; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; STEADY STATE; SUSTAINED RELEASE PREPARATION; XANTHIUM;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ASTHMA; BIOLOGICAL AVAILABILITY; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG; MALE; THAILAND; THEOPHYLLINE;

EID: 0034754116     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients
2. Improved control of asthma in the office setting. A large-scale study of once-daily evening doses of theophylline
3. Comparison of once-a-day and twice-a-day theophylline in asthma
4. Update on the pharmacodynamics and pharmacokinetics of theophylline
5. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24
6. Theophylline absorption from SR products: Comparative steady-state bioavailability of once daily Theo-Dur, Theo-24 and Uniphyl
7. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system
8. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur)
9. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system
10. Food induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity
11. Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women
12. Bioequivalence requirement for generic products
13. Presentation of results from bioequivalence studies
14. Theophylline
15. Comparative study of the pharmacokinetic characteristics of slow release theophylline oral preparations in Thai children with persistent asthma
16. A single-dose comparison of three slow-release theophylline oral preparations in healthy Thai volunteers
17. Day-night patterns in bronchial patency and dyspnea: Basis for once-daily and unequally divided twice-daily theophylline dosing schedules
18. Treatment of asthma by a controlled-release theophylline tablet formulation: A review of the North American experience with nocturnal dosing
19. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics
20. Once-daily dosing of a new ultrasustained-release theophylline preparation
21. Improved control of asthma in the office setting. A large-scale study of once-daily evening doses of theophylline